BOT @ Lytham Partners 2025 Investor Healthcare Summit

Matt Callahan talks shop Click here

I didn't garner any ground breaking news from this, however:

Matt discussed the companies "social listening program" which has identified 435,000 HH sufferers discussing HH and its affects on their lives. This snooping in on conversations on social media platforms allows the company to Id potential future customers, put information in front of them and funnel them through to the Telehealth platform. This can be done right at the time that the HH sufferer is looking for information.

It is possible to be made aware of Sofdra, get diagnosed, then have Sofdra shipped and at your door all within 48 hours. As opposed to getting a referral to a Dermatologist via a GP and picking up Sofdra from the Pharmacy, a process that could take months.

While Sofdra was obviously a big focus right now, Matt highlighted the value in the development of the platform.